VBI Vaccines Inc.
VBIV · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $9 | $101 | $597 | $600 |
| - Cash | $24 | $63 | $122 | $94 |
| + Debt | $53 | $52 | $32 | $1 |
| Enterprise Value | $39 | $90 | $507 | $507 |
| Revenue | $9 | $1 | $1 | $1 |
| % Growth | 702.4% | 71.5% | -40.5% | – |
| Gross Profit | -$6 | -$10 | -$10 | -$8 |
| % Margin | -67% | -942.1% | -1,606.8% | -764.1% |
| EBITDA | -$83 | -$106 | -$63 | -$41 |
| % Margin | -953.5% | -9,798.5% | -9,954.7% | -3,888.5% |
| Net Income | -$93 | -$141 | -$73 | -$47 |
| % Margin | -1,069.3% | -13,026.9% | -11,513.5% | -4,456.7% |
| EPS Diluted | -5.96 | -16.37 | -8.55 | -6.5 |
| % Growth | 63.6% | -91.5% | -31.5% | – |
| Operating Cash Flow | -$61 | -$74 | -$40 | -$47 |
| Capital Expenditures | -$1 | -$4 | -$2 | -$1 |
| Free Cash Flow | -$62 | -$78 | -$42 | -$48 |